Change in global disease severity · Apathy in people with mild‐to‐moderate Alzheimer's disease
Methylphenidate showed no clear difference in change in global disease severity compared with placebo (moderate certainty).
1 finding from 1 review
Leaving the study early · Apathy in people with mild‐to‐moderate Alzheimer's disease
Methylphenidate showed no clear difference in dropouts compared with placebo (low certainty).
1 finding from 1 review
Gestational diabetes · pregnant women
Low‐GI dietary advice showed no clear difference in gestational diabetes compared with moderate‐ to high‐GI dietary advice (maternal outcomes) (low certainty).
1 finding from 1 review
Hypertensive disorders of pregnancy · pregnant women
1 finding from 1 review
Caesarean section · pregnant women
It is very uncertain whether low‐GI dietary advice changes caesarean birth compared with moderate‐ to high‐GI dietary advice (maternal outcomes) (very low certainty).
1 finding from 1 review
Perineal trauma · pregnant women
1 finding from 1 review
Gestational weight gain · pregnant women
It is very uncertain whether low‐GI dietary advice changes gestational weight gain (kg) compared with moderate‐ to high‐GI dietary advice (maternal outcomes) (very low certainty).
1 finding from 1 review
Postnatal depression · pregnant women
1 finding from 1 review
Type 2 diabetes mellitus · pregnant women
1 finding from 1 review
Perinatal mortality · pregnant women
1 finding from 1 review
Large‐for‐gestational age · pregnant women
It is very uncertain whether low‐GI dietary advice changes large‐for‐gestational age compared with moderate‐ to high‐GI dietary advice (child outcomes) (very low certainty).
1 finding from 1 review
Mortality or morbidity composite · pregnant women
1 finding from 1 review
Neonatal hypoglycaemia · pregnant women
1 finding from 1 review
Childhood/adulthood adiposity · pregnant women
1 finding from 1 review
Childhood/adulthood type 2 diabetes mellitus · pregnant women
1 finding from 1 review
Neurosensory disability · pregnant women
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with a serious adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
At least 50% of maximum pain relief over 4 to 6 hours · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Median (mean) time to use of rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review